Revacept: Clinical Trials

1 trial of Revacept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Revacept: new trials by email Literature Review of Revacept trials Research Report on Revacept

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
revacept (PR-15) - Thrombosis, Acute Coronary Syndrome
Phase 1CompletedAdvanceCor GmbH302006-03-012012-10-19

Conditions studied

Acute Coronary Syndrome (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)  ·  Thrombosis (1)

Sponsors

AdvanceCor GmbH (1)

Countries

Germany (1)

Top investigators

Richard Piechatzek, MD (1)

Results publications

PMID 21502572